Cargando…
Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application
BACKGROUND: Graves’ orbitopathy (GO) is the most frequent extrathyroidal manifestation of the autoimmune Graves’ disease. GO significantly impacts quality of life and has a psycho-social morbidity. Inflammation and swelling of the orbital tissue often leads to proptosis, diplopia, and decrease of vi...
Autores principales: | Längericht, Jan, Krämer, Irene, Kahaly, George J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745544/ https://www.ncbi.nlm.nih.gov/pubmed/33403097 http://dx.doi.org/10.1177/2042018820958335 |
Ejemplares similares
-
Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021) -
Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015) -
Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020) -
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021) -
SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)